Best Dental Implant Brands: A Comprehensive Comparison

2026 Brand Comparison Matrix: At a Glance

The following table compares the top dental implant brands across key clinical and commercial factors:

Use our side-by-side brand comparator tool to compare any two brands in detail.

Premium Tier: Straumann, Nobel Biocare, ZimVie

Straumann Group — The Global Market Leader

Straumann Group reported CHF 2.6 billion in revenue for full-year 2025 with 8.9% organic growth, and projects high single-digit organic growth for 2026 (Straumann Annual Report). The company holds approximately 22.5% of the global dental implant market and roughly 35% of the US market (iData Research 2024), making it the undisputed market leader. Straumann controls almost half the global premium segment and ~15% of the value segment through its multi-brand portfolio.

• Roxolid alloy (85% Ti / 15% Zr): A proprietary titanium-zirconium blend confirmed at 85% titanium and 15% zirconium (straumann.com). This alloy delivers higher tensile strength than commercially pure titanium (Grade 4), enabling narrower implant diameters (as small as 3.3mm) that preserve more natural bone in tight interdental spaces — particularly critical in mandibular incisors and narrow alveolar ridges.
• SLActive surface: A hydrophilic (water-attracting) surface created by sandblasting, acid-etching, and chemical activation under nitrogen protection. This surface significantly accelerates osseointegration — reducing healing time from 6–8 weeks to 3–4 weeks in ideal conditions. SLActive is the most extensively documented fast-healing surface in implant dentistry, with over 15 years of peer-reviewed clinical data.
• BLX implant system: Designed specifically for immediate loading protocols. Features a unique Velocity drill protocol and progressive thread design optimized for both high and low bone density. Combines with SLActive surface for the fastest documented integration in immediate-load cases.
• iEXCEL system (launched 2025): Straumann's newest generation implant platform designed to improve clinical outcomes and practice efficiency. The iEXCEL rollout has already contributed to market share gains in mature European markets including Germany and Austria, targeting a 10% market share increase in its segment.
• Multi-brand strategy: Beyond the premium Straumann line, the group operates Neodent (mid-tier, strong in Latin America), Anthogyr (Europe-focused value tier), and Medentika (compatible prosthetics), allowing Straumann to compete across all price segments simultaneously.
• Clinical data: Over 20 years of peer-reviewed studies. 10-year survival rates consistently exceed 96%. The most extensively documented implant system in the world with the largest body of published clinical evidence of any implant manufacturer.

Best for: Patients who want the most clinically proven system with the fastest healing. Optimal for complex cases, narrow ridges, aesthetic zones, and immediate loading protocols. Full Straumann review →

Nobel Biocare (Envista Holdings) — The All-on-4 Pioneer

Nobel Biocare, a subsidiary of Envista Holdings Corporation (NYSE: NVST, spun off from Danaher in 2019), invented the All-on-4 treatment concept — the most widely adopted full-arch implant protocol in the world. Envista holds approximately 11.1% of the global implant market (ReportPrime 2024). In 2025, Nobel Biocare celebrated its 60th anniversary since the first titanium dental implant placement (1965), held at its Global Symposium in Las Vegas.

• TiUnite surface: A moderately rough, highly osteoconductive anodized titanium oxide layer. This microporous surface promotes rapid bone cell attraction (osteoblast adhesion) and has demonstrated strong long-term stability data across 30+ years of clinical documentation. TiUnite remains one of the most studied implant surfaces globally.
• All-on-4 protocol: Four strategically angled implants (posterior implants tilted up to 45°) support a complete arch of teeth, simultaneously reducing surgical complexity, bone grafting requirements, and cost. This proprietary protocol is the single most influential innovation in full-arch implantology. All-on-4 guide →
• Zygomatic implants: Nobel Biocare pioneered extra-long implants anchored in the zygomatic bone (cheekbone) for patients with severe maxillary bone loss — eliminating the need for bone grafts entirely. This remains a proprietary specialty with limited competition.
• Versah acquisition (February 2026): Nobel Biocare acquired Versah, the leader in osseodensification and bone densification technology. This technology uses specially designed burs to compact bone rather than remove it, improving primary stability in low-density bone — directly enhancing immediate loading success rates.
• Digital ecosystem: In December 2025, Nobel Biocare expanded its digital portfolio by launching the DEXIS Imprevo intraoral scanner. Combined with a strategic distribution partnership with 3Shape for TRIOS scanners (announced June 2025), Nobel now offers one of the most comprehensive digital impression workflows in the industry.
• Dual-brand strategy: Envista also operates Implant Direct, a value-tier brand using Nobel Biocare connection technology at lower prices, and Alpha-Bio Tec (Israel-based value brand), targeting mid-market and price-sensitive international markets.
• Clinical data: 10-year success rates exceed 95%. Extensive clinical documentation spanning 3+ decades and thousands of published studies.

Best for: Full-arch restorations (All-on-4/All-on-6), immediate function protocols, zygomatic anchorage, and clinics requiring comprehensive digital workflows. Full Nobel Biocare review →

ZimVie — The Bone Integration Specialist (formerly Zimmer Biomet Dental)

ZimVie spun off from Zimmer Biomet as an independent publicly traded company on March 1, 2022, inheriting Zimmer Biomet's dental and spine divisions. In December 2023, ZimVie sold its spine business to H.I.G. Capital ($375M) to become a pure-play dental company. In July 2025, ZimVie entered a definitive agreement to be acquired by ArchiMed for $730 million, with the transaction closing by end of 2025 — making ZimVie a privately held dental-focused company going forward.

• Trabecular Metal technology: Made from porous tantalum, this structure mimics human cancellous (spongy) bone at a structural level. Bone grows through the interconnected pores (not just around the surface), creating exceptional three-dimensional mechanical interlock absent in traditional implant designs. Originally developed for orthopedic joint replacement (20+ years of hip/knee data), now adapted for dental implantology. Particularly valuable for patients with osteoporosis or Type IV bone.
• T3 implant platform: Features the MTX (micro-textured) surface — a proprietary dual acid-etched texture — with optional HA (hydroxyapatite) coating for accelerated bone response during the critical first 2–4 weeks of healing.
• High primary stability design: Progressive thread geometry and tapered body optimized for immediate loading at insertion torque values of 35+ Ncm, even in compromised bone density scenarios where other systems may require staged protocols.
• Clinical data: Strong long-term evidence. The Trabecular Metal platform has over 20 years of successful orthopedic application data across millions of hip, knee, and shoulder implants — all supporting its unique bone integration properties. Dental-specific studies demonstrate excellent medium-to-long-term outcomes.

Important note (2026): Following the ArchiMed acquisition, ZimVie continues to operate as a dental company with expanded focus on Asia-Pacific markets and digital dentistry solutions (restorative and scanning). The Trabecular Metal technology remains fully available and supported. Patients with existing ZimVie implants should experience no changes in component availability or warranty support.

Best for: Patients with low bone density, osteoporosis concerns, or compromised healing conditions where maximum bone integration is critical. Full ZimVie review →

Value Tier: Korean Brands Reshaping the Global Market

South Korean manufacturers — led by Osstem, MegaGen, and Dentium — have fundamentally disrupted the global dental implant market over the past two decades. Osstem is now the #1 implant brand globally by unit volume sold and ranks #3 by market share (behind Straumann and Envista), while Korean brands collectively represent a significant and growing share of the global market. In South Korea alone, local manufacturers dominate 80% of the domestic implant market and hold the highest market share in China (geneonline.com).

Osstem Implant — Global Volume Leader

Founded in 1997 in Seoul, Osstem Implant achieved the position of world's #1 dental implant brand by sales volume as of 2024 (PR Newswire). The company's stated goal is to become the world's #1 dental company across all segments by 2036, with a revenue target of $6.74 billion. In the US market, Osstem operates through its Hiossen brand, which has rapidly grown its presence among US dentists and periodontists.

• SA surface (Sand-blasted, Acid-etched): Osstem's core surface treatment uses corundum (Al₂O₃) sandblasting followed by HCl/H₂SO₄ acid etching to create optimal micro-roughness for osseointegration. While less proprietary than SLActive or Xpeed, SA surfaces have the longest clinical track record of any implant surface type (25+ years globally).
• TS System: Osstem's flagship tapered implant system designed for versatility across bone types. Features a self-tapping design that simplifies surgical protocols and achieves high primary stability even in softer bone (Type III-IV).
• Clinical education model: Osstem differentiates through extremely aggressive clinical education programs, offering hundreds of courses annually worldwide. This educational infrastructure has created a large, loyal user base — particularly among younger practitioners and those in developing markets.
• Certifications: FDA 510(k) cleared, CE marked, ISO 13485 certified. Exported to 70+ countries.

Best for: Budget-conscious patients with adequate bone density and straightforward implant needs. Excellent choice when the treating dentist has extensive Osstem-specific experience. Full Osstem review →

MegaGen — The Surface Science Innovator

MegaGen has differentiated itself through its proprietary Xpeed surface technology and the aggressive AnyRidge implant system — designed for immediate placement and high primary stability even in compromised bone.

• Xpeed surface (CaTiO₃ nanostructure): MegaGen's patented surface treatment starts with standard SLA (Sand-blasted, Large grit, Acid-etched) and adds a hydrothermal calcium ion incorporation process that forms a calcium titanate (CaTiO₃) nanostructure on the implant surface. This is not mere coating — the calcium ions are chemically bonded into the titanium oxide layer. The Xpeed surface maintains a homogenous roughness value of Ra 1.8–2.5μm across the entire fixture, promoting uniform bone growth. Its distinctive blue color visually confirms the surface is 100% acid-residue-free. Clinical data spanning 10+ years demonstrates accelerated osseointegration with increased bone-to-implant contact (BIC) and higher removal torque values compared to standard SLA surfaces.
• AnyRidge system: Features an aggressive thread design with a unique knife-thread geometry that maximizes bone-to-implant contact area. The deep threads create exceptional primary stability, making AnyRidge a strong choice for immediate loading and extraction socket placement.
• Materials: MegaGen uses both Grade 4 commercially pure titanium and Ti-6Al-4V ELI (Extra Low Interstitials) depending on the implant system and diameter, providing flexibility for different clinical scenarios.
• Certifications: FDA 510(k) cleared, CE marked, ISO 13485 certified.

Best for: Immediate placement cases, soft bone scenarios, and clinicians who prioritize advanced surface chemistry at a value-tier price point. Full MegaGen review →

Dentium — Korea's SLA Pioneer

Established in June 2000 in Seoul, Dentium is recognized as the first South Korean company to successfully commercialize SLA surface treatment technology for dental implants. The company exports to over 70 countries and has built its reputation on reliable, straightforward implant systems at the lowest price point in the Korean tier.

• SuperLine implant system: Dentium's flagship system features a double-threaded, tapered body design for fast and easy insertion. A key advantage is interchangeable abutments across different implant diameters, simplifying prosthetic workflows and reducing the restorative component inventory that practices need to stock.
• SLA surface: Standard Sand-blasted Long grit, Acid-etched surface — the same fundamental technology used by Straumann (pre-SLActive) and many global competitors. While less advanced than MegaGen's Xpeed or Straumann's SLActive, SLA has the longest and most extensive clinical documentation of any implant surface type worldwide.
• R&D focus: Dentium operates a dedicated R&D center in South Korea and maintains an ongoing research program, though its investment level is smaller than Osstem or MegaGen.
• Certifications: FDA 510(k) cleared, CE marked, ISO 13485 certified.

Best for: Practices seeking the lowest-cost FDA-cleared implant option for basic single-tooth and straightforward multi-unit restorations. Full Dentium review →

Why Korean Brands Cost Less — The Economics

• Manufacturing scale: Korean companies produce implants at massive volume with highly automated production lines (especially Osstem, which manufactures millions of units annually). This dramatically reduces per-unit manufacturing costs.
• Lower R&D overhead: While Korean brands invest in innovation, their R&D budgets are substantially smaller than Straumann (which spent CHF 200M+ on R&D in 2025). This means fewer proprietary materials but significantly lower per-unit costs passed to clinicians.
• Deliberate market positioning: Korean companies intentionally target the value segment to capture global volume, particularly in Asia, Latin America, the Middle East, and Eastern Europe, before expanding into premium Western markets (a strategy that has proven highly successful for Osstem).
• Fixture cost to dentist: Korean implants cost practices $50–$150 per fixture vs $300–$500 for premium brands. A portion of these savings is passed to patients, but the practice margin often remains similar or even higher per case.

Are Korean Implant Brands Safe?

Yes — all implants sold in the US must be FDA 510(k) cleared. Korean brands undergo the same regulatory review process and meet the same safety and efficacy standards as Swiss, German, or American brands. However, there is an important clinical nuance:

• Premium brands (Straumann, Nobel Biocare) have 20–30+ years of peer-reviewed clinical data from Western research institutions documenting long-term outcomes across diverse patient populations.
• Korean brands typically have 10–15 years of Korean/Asian clinical data and 5–10 years of Western clinical data. Their success rates are excellent in short-to-medium-term studies (95–98%), but fewer long-term (15+ year) studies with Western patient populations exist.
• From a regulatory standpoint, all brands meet identical safety thresholds. The clinical evidence gap is narrowing each year as Korean brands increasingly publish in European and American peer-reviewed journals.

For most patients with normal health and adequate bone, this difference is clinically insignificant. But if you have compounding risk factors (low bone density, uncontrolled diabetes, immunosuppression, heavy smoking), the deeper clinical certainty of a premium brand with 20+ year outcome data may provide meaningful additional confidence.

Implant Material Science: What Your Implant Is Made Of

Not all titanium is the same. The material your implant is made from directly affects its strength, biocompatibility, and long-term durability:

Key takeaway: For most patients, Grade 4 Titanium or Roxolid provides the best combination of strength, biocompatibility, and clinical evidence. Zirconia is the choice for patients with confirmed metal allergies or high aesthetic demands (visible front teeth area). Trabecular Metal is ideal for compromised bone situations.

Surface Treatment Technology: Why It Matters More Than the Brand Name

The surface treatment of an implant is arguably more important than the brand itself — it determines how quickly and strongly bone integrates with the implant. Here are the major surface technologies:

When comparing quotes from different dentists, ask which surface technology the implant uses — this gives you more meaningful information about expected healing time and integration quality than the brand name alone.

How to Choose the Right Implant Brand

Your dentist will recommend a specific brand and system based on your clinical situation. However, understanding these factors helps you ask the right questions:

Choose a Premium Brand If:

• You have compromised bone density or health conditions (diabetes, osteoporosis)
• You want the fastest possible healing time (SLActive, TiUnite)
• You are getting implants in the aesthetic zone (front teeth visible when smiling)
• You want maximum long-term clinical evidence backing your implant
• You are undergoing complex procedures (All-on-4, zygomatic implants)

Choose a Value Brand If:

• You are in good overall health with adequate bone density
• Budget is a primary concern (see affordable options)
• You are replacing posterior teeth (less visible, less aesthetic demand)
• Your dentist has extensive experience with the specific brand
• You are getting a straightforward single or double implant case

Questions to Ask Your Dentist

1. "Which implant brand and system do you recommend for my case, and why?"
2. "What surface treatment does this implant use, and how does it affect healing time?"
3. "How many implants of this brand have you placed in the past year?"
4. "What is the manufacturer's warranty on this implant?"
5. "Would a different brand significantly change my expected outcome or cost?"

Critical insight: The surgeon's experience with a specific system often matters more than the brand itself. A dentist who has placed 500 Osstem implants will likely achieve better outcomes with Osstem than with a premium brand they have less experience with. Always prioritize surgeon expertise and comfort level with the chosen system.

Brand Warranty & Support Comparison (2026)

One of the most overlooked differences between implant brands is warranty and component availability — a factor that matters enormously if you ever need replacement parts 10 or 20 years after placement:

Why this matters: If you move to a different city or country, or if your dentist retires, you need a new provider who can access compatible replacement abutments, screws, and prosthetic components. Premium brands with 20+ year component guarantees and global distribution networks provide significantly more long-term security. With value brands, component availability may vary by region and is less guaranteed over very long time horizons.

2025–2026 Industry Consolidation: What Patients Should Know

The dental implant industry is undergoing significant consolidation and ownership changes, which may affect brand availability, pricing, and component support in the coming years. Here is the verified timeline of major corporate changes:

What this means for patients: Industry consolidation can affect component pricing, warranty support, and continuity of care. When choosing a brand, consider the long-term financial stability of the manufacturer — a company that may be acquired or restructured could potentially discontinue specific product lines. As of 2026, the safest bets for long-term continuity are Straumann Group (independently publicly traded, CHF 2.6B revenue) and Envista/Nobel Biocare (NYSE-listed, diversified dental portfolio).

The Compatibility Factor: Why Brand Lock-In Matters

One critical factor that most patients don't consider until it's too late: dental implant brands are NOT interchangeable. Once a specific brand's fixture is placed in your jaw, you are effectively locked into that brand's prosthetic component ecosystem:

• Connection type: Each brand uses a proprietary internal connection geometry (hex, conical, tri-channel, etc.). A Straumann abutment physically cannot connect to a Nobel Biocare fixture. This means all future crown replacements, abutment changes, and repairs must use compatible components.
• Abutment compatibility: If your brand is discontinued or your region loses dealer support, sourcing replacement abutments becomes difficult and expensive. Third-party compatible abutments exist but may not provide the same precision fit as OEM (original equipment manufacturer) parts.
• Switching cost: If a brand becomes unavailable, the only option is surgical removal of the fixture and complete reimplantation with a new system — a procedure costing $3,000–$8,000+ and requiring months of additional healing.
• Multi-implant cases: If you need additional implants later (e.g., losing another tooth in 5–10 years), using the same brand and connection type across all implants simplifies prosthetic planning and reduces long-term maintenance costs.

Practical recommendation: Choose a brand with strong long-term distributor relationships in your region. Ask your dentist: "If I need replacement parts in 15 years, how confident are you that this brand will still be available here?" This single question reveals more about the practical choice between brands than any clinical data comparison.

Individual Brand Reviews

Explore our in-depth reviews of each dental implant brand, including detailed specifications, clinical evidence, pros & cons, and guidance on whether each brand is right for you.

• Anthogyr — $1,700 avg, 97.5% success rate
• BTI Biotechnology Institute — $1,600 avg, 97.5% success rate
• Bicon Dental Implants — $2,000 avg, 97.5% success rate
• Camlog Biotechnologies — $1,700 avg, 97.5% success rate
• Dentsply Sirona (Astra Tech) — $1,850 avg, 98.0% success rate
• Neoss — $1,600 avg, 98.6% success rate
• Nobel Biocare — $1,950 avg, 98.5% success rate
• SIC Invent — $1,500 avg, 97.5% success rate
• Straumann — $2,000 avg, 98.8% success rate
• Thommen Medical — $1,800 avg, 98.0% success rate
• ZimVie — $1,800 avg, 98.7% success rate
• Zimmer Biomet — $1,800 avg, 98.0% success rate
• AB Dental — $900 avg, 96.5% success rate
• Adin Dental Implants — $900 avg, 96.5% success rate
• Alpha-Bio Tec — $1,000 avg, 97.0% success rate
• Besmile — $700 avg, 96.0% success rate
• BioHorizons — $1,500 avg, 97.5% success rate
• Biotech Dental — $1,200 avg, 97.0% success rate
• Bredent Medical — $1,300 avg, 97.0% success rate
• Cortex Dental Implants — $800 avg, 96.0% success rate
• Euroteknika — $1,100 avg, 96.5% success rate
• Glidewell Dental — $1,000 avg, 97.0% success rate
• IDI (Implants Diffusion International) — $1,100 avg, 96.5% success rate
• Keystone Dental — $1,300 avg, 97.0% success rate
• MIS Implants — $1,100 avg, 97.0% success rate
• Medentika — $1,100 avg, 97.0% success rate
• Megagen Implant — $1,100 avg, 97.0% success rate
• Neodent — $1,200 avg, 97.5% success rate
• Noris Medical — $800 avg, 96.0% success rate
• SGS Dental Implant System — $1,200 avg, 96.5% success rate
• Southern Implants — $1,100 avg, 97.0% success rate
• Sweden & Martina — $1,200 avg, 97.0% success rate
• TBR Dental Group — $1,200 avg, 96.5% success rate
• Zest Dental Solutions — $1,200 avg, 97.0% success rate
• Baikang Dental — $550 avg, 95.0% success rate
• Bioconcept — $600 avg, 95.0% success rate
• Blue Sky Bio — $700 avg, 96.0% success rate
• CDIC — $500 avg, 98.0% success rate
• Cowellmedi — $800 avg, 96.0% success rate
• DIO Implant — $850 avg, 96.5% success rate
• Dentium — $950 avg, 97.0% success rate
• Hiossen (Osstem) — $900 avg, 96.5% success rate
• Implant Direct — $900 avg, 96.5% success rate
• Kangsheng — $550 avg, 95.0% success rate
• Kontec — $500 avg, 95.0% success rate
• Leiden BLB — $550 avg, 95.0% success rate
• Shinhung — $750 avg, 96.0% success rate
• Trausim — $650 avg, 95.5% success rate
• Warantec — $700 avg, 95.5% success rate
• Wego Dental — $600 avg, 95.0% success rate

Browse all brands → · Compare brands side by side →